ABSTRACT In normal kidneys the renal medulla very efficiently converts arachidonic acid to prostaglandins. Although the renal cortex has only trace amounts ofcyclooxygenase activity, we report here the existence ofan active cortical NADPH-dependent monooxygenase that converts arachidonate primarily into 19-hydroxy-and 20-hydroxyarachidonate as well as 19-ketoarachidonate and a dicarboxylic acid. The enzyme is presumably a cytochrome P450 monooxygenase and demonstrated marked resistance to inhibition by 2-diethyaminoethyl-2,2-diphenylvalerate hydrochloride (SKF-525A), metyrapone, and carbon monoxide. In the rabbit kidney these products are produced only by the cortex in the presence of NADPH and represent the major metabolic products of arachidonate metabolism.
METHODS AND MATERIALS
New Zealand White male rabbits weighing 2.5-3.0 kg were anesthetized with pentobarbital (30 mg/kg intravenously) and the kidneys were removed and placed in ice-cold saline. The cortex and medulla were separated and each was homogenized (Tekmar Homogenizer, Cincinnati, OH) in 4 parts (wt/vol) 50 mM Tris-HCl buffer, pH 7.5, containing 2 mM EDTA. In some experiments indomethacin was included in the homogenizing buffer at 2 ,ug/ml. The homogenate was then sedimented at 10,000 x g in a refrigerated Sorval centrifuge for 15 min at 4°C. The supernatant was used as a source of enzyme. Incubations were carried out with ['4C ]arachidonic acid (specific activity 55 mCi/mmol, New England Nuclear; 1 Ci = 3.7 X 1010 becquerels) as the substrate. At the end of incubation the lipids were extracted after acidification to pH 3.5 with 1 M HC1 and subjected to chromatography. For thin-layer chromatography (TLC) separations, the extraction was with two equal volumes ofethyl acetate followed by centrifugation at 2500 x g, then the supernatant was evaporated to dryness under a stream of N2.
For high-pressure liquid chromatography (HPLC), the extraction was carried out with 2 vol ofmethanol. After centrifugation, the lower phase was extracted with 1 vol of methanol, the supernatants were pooled and acidified to pH 3.5 with 0. 1 M HCl, and 6 vol of diethyl ether and 4 vol of water were added. The ether phase was removed and washed with 2 vol of water, ethanol was added to the ether phase (1 ml of ethanol to 10 ml ofether) so that the water could be removed azeotropically, and the solution was evaporated to dryness in a rotary evaporator. The total lipids were then reconstituted in a small volume (500 g1l) ofappropriate organic solvent prior to chromatography. For experiments with microsomes, the 10,000 x g supernatant was centrifuged at 100,000 x g for 60 min and resuspended in onefourth the original wet weight of 50 mM potassium phosphate buffer.
Chromatography. (i) TLC was carried out on silica gel G (Brinkman Sil G) plates developed in the organic phase ofethyl acetate/2,2,4-trimethylpentane/aceticacid/water(110:50:20:100, vol/vol). The developed plates were exposed to Kodak X-Omat film for 48 hr. Alternatively, we used a system of benzene/ diethyl ether/ethanoVacetic acid (50:40:2:0.2, vol/vol), which more effectively separated the nonpolar products ofarachidonic acid.
(ii) For HPLC we used two Waters 6000A solvent delivery systems, a U6K injector with a 2-ml loading loop, a model 600 programmer, Waters ,Porasil and ,uBondpak analytical columns and a Waters semipreparative ,Porasil column. Aliquots (50 ,ul) of the fractions were removed for determination of radioactivity in a liquid scintillation counter. The solvents used will be detailed in Results. Protein was measured by the method of Lowry et al (7) .
Gas Chromatography/Mass Spectrometry. The radioactive compounds eluting during the HPLC were converted to the methyl esters with ethereal diazomethane and compounds containing hydroxyl groups were converted to the trimethylsilyl ethers with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) containing 1% trimethylchlorosilane or were converted to t-butyl derivatives with t-butyldimethylsilylchlorosilane/imidazole reagent (Applied Science). The reaction was carried out at 40°C for 2 hr or overnight at room temperature in a 50:50 mixture of BSTFA and pyridine for the trimethylsilyl ether. For tbutyl derivatives the reaction was carried out overnight at room temperature. For isothermal gas chromatography we used a 3% OV-101 (Applied Science) column 2 m long and 2 mm inside diameter, with injector at 250°C and column at 220°C and carrier N2. The gas chromatograph was interfaced with a Finnigan 3300 mass spectrometer. The ionization voltage was 70 eV. The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Ag/ml, but 5,8,11,14-icosatetraynoic acid at concentrations of 100 Ag/ml inhibited conversion by 45%. The enzymatic conversion of arachidonate to the nonpolar metabolites was linear with protein concentration between 0.25 and 4 mg/ml. In addition, at concentrations ofprotein greater than 4 mg/ml a third zone of radioactivity was noted: compound III, which had a chromatographic mobility in the TLC system indicating it was less polar than compound I and had an R value of 0.82.
A Cortical whole homogenates, 10,000 x g pellets, 10,000 X g supernatants, 100,000 X g supernatants, and 100,000 X g pellets were incubated with ['4C]arachidonic acid. The 10,000
x g supernatant converted ["4C]arachidonate to at least three nonpolar compounds. The 100,000 x g supernatant and the 100,000 x g pellet did not alter arachidonate, but when mixed together they essentially reconstituted the 10,000 X g supernatant and converted the arachidonate to the nonpolar products previously described. One explanation for the mixing experiment was that the 100,000 x g supernatant contained a cofactor or cofactors necessary for full expression of a membrane-bound enzyme present in the 100,000 x g pellet. To test this hypothesis we added NADPH and NADH (1 mM) to the incubations of 100,000 X g pellet with arachidonic acid (10 AM). The addition of NADPH to the 100,000 X g pellet stimulated conversion of arachidonate to nonpolar compounds with Rf values similar to those obtained when the 10,000 x g supernatant was used. The enzyme had an absolute requirement for NADPH; NADH did not stimulate conversion ofarachidonate. SKF-525A at concentrations up to 100 ,g/ml (0.28 mM) and metyrapone at 0.1 mM and 1 mM did not inhibit product formation, but at 10-fold higher concentrations there was 50% inhibition of activity. SKF-525A and metyrapone were used because they are inhibitors of the cytochrome P450 mixed-function oxidase system.
The Rf values of the nonpolar compounds formed from arachidonate were very similar to the Rf values reported for the 12-OH, 8-OH, and 9-OH icosanoids of the lipoxygenase pathways (8) . However, they were not detected by UV absorbtion at 233 or 280 nm, which suggested that these compounds lacked the conjugated diene or triene structure characteristic of the lipoxygenase products. Furthermore, the 45% inhibition by 5,8,11,14-icosatetraynoic acid at a concentration of 100 ,g/ml indicated a greater resistance to inhibition than the lipoxygenase enzymes and suggested that the compounds produced did not involve the lipoxygenase pathways. In an attempt to identify the structure of these compounds we incubated 2. The mass spectra ofcompounds A, B, and C are shown in Fig.  3 A, B , and C. Fig. 3A represents the mass spectrum of the methyl ester of compound A from HPLC. The mass spectrum showed ions ofhigh intensity at mass-to-charge ratios (m/z) 332 Biochemistry: Morrison . This spectrum suggests the compound is 19-hydroxyicosatetraenoic acid. The gas chromatographic column used separated the products ofthe most polar peak (peak C) into two compounds. The major product was the 19-hydroxy compound and the lesser one, with a longer retention time, had a molecular weight of 448 as the t-butyl derivative and may represent the 20-hydroxylated compound. The molecular weight of compound C was further confirmed by making a t-butyldimethylsilyl ether, which gave a prominent M+ -57 ion at 391 on mass spectrometry.
DISCUSSION
The observations presented suggest that arachidonic acid is a natural substrate for the rabbit renal cortical monooxygenase systems and the fatty acid undergoes hydroxylations at positions 19 and 20. These hydroxylations are similar to those described in liver for PGE1 and PGE2 (9) and PGA1 and PGE1 (10) and suggest that they were mediated by NAD(P)H-dependent cytochrome P450 enzymes. It is of some interest that these hydroxylating enzymes demonstrated an absolute requirement for NADPH, and that NADH at 1 mM could not support their oxygenase activity. Thus these enzymes are similar in cofactor requirements to the guinea pig renal cortical monooxygenase with PGE1 as substrate (11) . The major hydroxylations appeared to be at position 19. Orrenius has studied the various fatty acid oxygenations and found a decrease in co/(w -1) hydroxylation ratio with increasing carbon atom chain length (12) . However, he did not report on the oxygenation ofarachidonate. This polyunsaturated fatty acid (C20J4), which has been demonstrated to be a substrate of another oxygenase (the cyclooxygenase) in renal cortex (13) , can thus be metabolized to classic prostaglandins and thromboxanes. We have demonstrated metabolism through a NADPH-dependent cytochrome P-450 system to 19-hydroxy and 20-hydroxy fatty acids, and in addition arachidonate is converted to 19-keto arachidonate and a dicarboxylic acid.
These products appear to be the major metabolites of arachidonate by the renal cortex in vitro when the reactions proceed in the presence of NADPH.
The kinetic parameters obtained refer to synthesis of 19-hydroxylation, because in our hands this appears to be the major product formed (compound I) and here a Km of 166 ,uM and a Vm. of 8.7 nmol per mg of protein per 60 min were obtained.
Our studies using inhibitors ofthe cytochrome P-450 system are also very interesting and different from the results obtained from guinea pig liver monoxygenase using PGAI and PGEI as substrates. Kupfer et al. (10) showed 60% inhibition of hepatic monooxygenase activity with SKF-525A (1 mM) and metyrapone (5 mM) and about 80% inhibition with CO/02/N2 (5:1:4, vol/vol). In our hands SKF-525A at 100 ,ug/ml (0.28 mM) and metyrapone at 1 mM had no effect on monooxygenase activity. However, at 10-fold higher concentrations SKF-525A and metyrapone oxygenase activity was inhibited by 50%. Thus the rabbit renal cortical enzyme appeared to be fairly resistant to several cytochrome P-450 enzyme inhibitors. This was also demonstrated in experiments with carbon monoxide when we used a C0/O2/CO2 mixture (1:1:0.5, vol/vol) and found no inhibition of oxygenase activity. This observation was similar to that observed for hydroxylation of PGE1 by guinea pig renal cortical microsomes (total lack ofinhibition by carbon monoxide) but is in contrast to the marked inhibition by CO of laurate hydroxylation with rat kidney cortex microsomes (11) .
The biology of these compounds awaits further definition; however, the kidney appears to have a clear separation in cortical and medullary arachidonate metabolic activity.
